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ABSTRACT 
Famotidine (FMT) and ibuprofen (IBU) were used as model drugs to obtain co-amorphous 
systems, where the guanidine moiety of the antacid and the carboxylic group of the NSAID, 
could potentially participate in H-bonds leading to a given structural motif. The systems 
were prepared in 3:7, 1:1 and 7:3 FMT and IBU molar ratios, respectively. The latter two 
became amorphous after 180 minutes of co-milling. 1:1 FMT-IBU exhibited a higher 
physical stability in assays at 4, 25 and 40 °C up to 60 days. FTIR spectroscopy accounted 
for important modifications in the vibrational behavior of those functional groups, allowing 
to ascribe the skill of 1:1 FMT-IBU for remaining amorphous to equimolar interactions 
between both components. DFT calculations followed by QTAIM analysis were then 
conducted to support the presence of the expected FMT-IBU heterodimer with 
consequently formation of a 8	structural motif. The electron density (ρ) and its Laplacian 
(∇2ρ) values suggested a high strength of the specific intermolecular interactions. 
Molecular Dynamics simulations to build an amorphous assembly, followed by RDF 
analysis on the modeled phase were further employed. The results demonstrate that is 
feasible a rational design of a co-amorphous system, satisfactorily stabilized by molecular-
level interactions leading to the expected motif. 
1. INTRODUCTION  
The major issue of orally administered marketed drugs is currently their limited water 
solubility.  Grohganz et al.1 and Rumondor et al.2 reported that more than 90% of new 
candidates to reach the market shows poor aqueous solubility. Several formulation 
strategies have been used to overcome this problem: reduction of the particle size                                    
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(nano-drug delivery),3 preparation of salts, cocrystals (i.e. crystal engineering)4,5 or 
inclusion complexes,6 or the use of lipid based vehicles.7 In addition to these alternatives, 
the obtainment of amorphous phases of active pharmaceutically ingredients (APIs) is a 
potent tool to improve pharmacokinetic parameters such as solubility and intrinsic 
dissolution rate8. In this sense, two techniques have been broadly explored: the solid 
dispersion technology9 and, the obtainment of co-amorphous (CAM) phases – so called co-
amorphous formulations– consisting of two low molecular weight molecules in 
stoichiometric ratios that stabilize each other in the amorphous form.10 However, the CAM 
phases are preferred over the formulations obtained by the solid dispersion method due to a 
series of advantages, such as i: do not show procedural disadvantages like hygroscopicity, 
that reduces the glass transition temperature (Tg) leading to phase separation and further 
recrystallization; in addition, due to the limited miscibility of some drugs in the polymer, 
large quantities of polymer for an appropriate drug loading are required, and ii: higher 
physical stability, solubility and increased intrinsic dissolution velocity.11 It is noteworthy 
that co-administration of two APIs, as an amorphous powder in a single formulation, 
provides compliance-related benefits since it implies simplicity for the patient and fewer 
administrations that ensure a more efficient treatment. Therapeutic advantages can also be 
achieved by a convenient combination of drugs where for example, one prevents the side 
effects of the other. The improvement in the physicochemical properties is mainly 
attributed to the new intermolecular interactions between the components of the system. 
Moreover, the lower molecular mobility of CAM phases and consequently, their lesser 
ability to nuclear and recrystallize respecting monocomponent amorphous forms, is also 
ascribed to these interactions.12 In spite of the relevance of such interactions in CAM 
systems (CAMs), they still play a secondary role in the study of these phases. This 
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observation is mainly attributed to the fact that several works are focused on the synthesis 
and further study of the presence or absence of intermolecular interactions,13,14,15 without 
taking into account their importance. The first works dealing with rationalized 
intermolecular interactions in CAMs involved a drug and an amino acid as 
excipient.16,17,18,19,20,21 Such studies were based on the assumption that if APIs interact at 
the molecular level with the target sites of their respective receptor proteins, they also may 
able to interact with amino acids in CAM. Recently, Korhonen et al.22 reported a study with 
a coherent selection of excipients, concluding that no preliminary rational design for the 
synthesis of CAM phases can ensure the physical stability of these systems. 
Although the amorphous state does not show a long range tridimensional order, the 
formation of heterodimers in CAMs is already reported by Löbmann, K. et al. where it was 
suggested that naproxen and indomethacin stabilize through O-H···O forming a R2
2
8 
structural motif involving the complementary carboxylic moieties of both drugs.23,24 In 
addition, the presence of heterotrimers was also proposed in CAM solids. Dengale et al.25 
proposed that ritonavir and quercetin form heterotrimers possibly by O-H···O 
intermolecular interactions. Both CAMs fulfill the rule formulated by Etter for H-bond 
interactions,26,27 which establishes that for a multifunctional system, the best donor atom in 
a given molecule preferentially interacts with the best acceptor belonging to the other, 
whereas the second best donor-acceptor pair will interact each and so on.  
In the present work, ibuprofen (IBU) and famotidine (FMT) (Figure 1Aa and 1Ab, 
respectively) were selected to prepare a CAMs to probe that a rational design, leading to a 
desired structural motif constructed by specific N-H···O and O-H···N intermolecular 
interactions, can be performed. Multiples H-bond donors and acceptors are observed in the 
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chemical structure of FMT, the imine nitrogen atom (N3) being the most basic28,29 and 
therefore, the most appropriate to participate in H-bond interactions with a given donor 
group.  On the other hand, the hydroxyl group (H-O1) of the carboxylic moiety is the main 
H-bond donor in IBU.30 Taking into account the previous analysis and the Etter´s rule, is 
feasible that FMT and IBU interact through these functional group (O1-H(IBU)···N3(FMT)). 
Moreover, the carbonyl oxygen atom of IBU could participate as H-bond acceptor with the 
primary amines of FMT (N(1 or 2)-H(FMT)···O2(IBU)). Both proposed intermolecular 
interactions would be able to give rise FMT-IBU heterodimers with consequent formation 
of a R 2
2
8 structural motif (Figure 1B). 
 
Figure 1: A) Chemical structure and atom numbering of IBU (a) and FMT (b). 
B) Proposed interactions in the FMT-IBU CAMs. 
 The co-milling technique is a widely used method to amorphize APIs. Thus, different 
molar ratios of polymorph A of famotidine (A-FMT) and IBU (3:7, 1:1 and 7:3, 
respectively) were co-milled during several periods. The resulting binary systems were 
characterized by an adequate combination of solid state techniques such as DRXP, 
Polarized Light Thermal Microscopy, DSC and FTIR spectroscopy. Moreover, theoretical 
calculations were performed due to their invaluable assistance in the study of amorphous 
a
b
A B
IBU
FMT
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phases where obviously, no structural information by diffraction technique is available. 
Then, the feasibility of formation of heterodimers FMT-IBU was evaluated by DFT 
calculations whereas the strength of the intermolecular interactions between the APIs was 
estimated by means of QTAIM analysis. Molecular Dynamics (MD) simulations on a 
modeled co-amorphous solid were further performed not only to study the intermolecular 
interactions but also the H-bonds distribution in this system by Radial Distribution 
Function (RDF) analysis.  
2. EXPERIMENTAL SECTION  
2.1. Materials  
FMT (MW: 337.4 g mol-1) was purchased from Fluka® as a polymorphic mixture of A and 
B forms (A-FMT and B-FMT, respectively) and used as received. The A-FMT, used in the 
binary systems preparation, was obtained as described in Hassan et al.31 and tested by 
comparing the corresponding powder X-ray diagram and IR spectrum with those reported 
in the literature.32 Raw IBU (MW: 206.29 g mol-1) 97.8% was provided by the Drug 
Quality Control Laboratory (National University of San Luis). Its purity was determined by 
HPLC analysis using IBU 99.8% sourced from Sigma® as standard. 
2.2. Methods 
2.2.1. Preparation of amorphous phases 
Amorphous ibuprofen and famotidine 
Ibuprofen and famotidine did not amorphize by milling and instead their amorphous phases 
could be prepared by quench-cooling. IBU powder (~3 mg) was placed in an aluminum pan 
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with cover and melted upon heating in the differential scanning calorimeter (DSC; see 
description below for further instrumental details). Then, the DSC was fastly cooled to −80 
°C and further heated to 150 °C at 10 ºC min−1; the glass transition temperature (Tg) of the 
amorphous phase was detected during the second step of heating. Raw FAM (~50 mg) was 
taken in a silica crucible and completely melted in a hot plate. Liquid nitrogen was 
carefully poured upon the melted compound. Once the sample solidified, ~ 3 mg were 
analyzed by DSC to determine the Tg by heating up to 100 ºC. 
Co-amorphous systems 
The pure drugs and the binary systems at 3:7, 1:1 and 7:3 molar ratios of A-FMT and IBU, 
respectively, were co-milled using an oscillatory ball mill Mixer Mill MM400 RETSCH, 
placing 200 mg of each sample in a 25 mL volume stainless steel milling jar containing 
three 7 mm diameter stainless steel balls. The milling conditions were fixed at a frequency 
of 30 Hz during 180 minutes and the jar was immersed into liquid nitrogen each 20 
minutes. The process was conducted in a room at 25 ± 2 °C. The samples were analyzed as 
soon as they were obtained. Physical mixtures in the same molar ratios were also prepared 
by mixing both APIs with a spatula in a mortar in order to perform some comparisons with 
the co-milled ones when was necessary. 
2.2.2. X-ray powder diffraction (XRPD) 
X-ray powder diffraction patterns were obtained with a Rigaku ULTIMA IV diffractometer 
operating at 25 ºC with CuKα radiation (Ni-filter) and NaCl and quartz as external 
calibration standards. The diffractograms were recorded in the 2θ angle range 3-45º and the 
process parameters were set at 0.02 2θ scan step size and 2s scan step time. 
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2.2.3. Differential Scanning Calorimetry (DSC) 
DSC curves were obtained with a Shimadzu TA-60WS Thermal Analysis System using 3-5 
mg of each sample in open aluminum pans with flowing air at 50 mL min-1 and a heating 
rate of 10 ºC min-1 from  -30 to 200 ºC (Figure S1). Calibration of the DSC instrument was 
carried out using indium as standard. The Tg was determined as the midpoint of the change 
in the heat capacity of the samples, while both Tc (recrystallization temperature) and Tm 
(melting temperature) were determined as the onset temperatures. Each assay was 
performed in triplicate.  
The experimental Tg values of the CAM samples were compared with the predicted Tg 
values from the Gordon-Taylor equation:  
	(	
) =
			
	
				 (1) 
where Tg(mix) is the glass transition temperature of the CAM binary system, w1 and w2 are 
weight fractions, K is a constant and Tg1 and Tg2 are the experimental Tg values of 
components 1 and 2, respectively. K was calculated as: 
 =
		
	
				(2)				 
where ρ1 and ρ2 are the densities of the pure amorphous compound. In this paper, the 
density values employed were the corresponding to the crystalline drugs (A-FMT = 1.595 g 
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cm-3 33 and IBU = 1.396 g cm-3 34). As it was described by Alleso, M. et. al.35, this 
approximation is valid for small molecules such as those used in this work.36,37  
 
2.2.4. Thermogravimetric Analysis (TGA) 
TG curves were obtained with a Shimadzu TGA 51 thermal analyzer using platinum pans, 
flowing oxygen at 50 mL min-1 and a heating rate of 10 ºC min-1 from room temperature to 
250 ºC.  
2.2.5. Polarized Light Thermal Microscopy (PLTM) 
Hot-stage microphotographs were acquired in a Linkam Hot-Stage system, model 
THMS600 equipped with a Leica DM2500 microscope and a Pixelink PL-A662 video 
camera. LINKSYS 32 DV-NC system software by Linkam, was used for temperature 
control, image record and analysis. The images were obtained by the combined use of 
polarized light and wave compensators using a 10X magnification. 
2.2.6. Fourier Transform Infrared Spectroscopy 
Fourier Transform Infrared (FTIR) spectra were recorded on a Nicolet PROTÉGÉ 460 
spectrometer provided with a CsI beamsplitter in the 4000-400 cm-1 range with 64 scans 
and a spectral resolution of 2 cm-1 using the KBr pellet technique. 
2.2.7. Stability studies  
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The amorphous co-milled binary systems (1:1 and 7:3 FMT-IBU) were stored in 
desiccators under dry conditions (silica gel) at 4, 25 and 40 °C up to 60 days. The physical 
stability was further analyzed by XRPD.   
2.2.8. Computational methods 
2.2.8.1. DFT calculations 
Geometry optimizations without any symmetry constraints were carried out with 
GAUSSIAN 0938 package at Density Functional Theory (DFT) level of theory adopting the 
popular B3LYP hybrid approximations for the exchange–hybrid correlation functional.39 A 
standard 6-311G(d,p)40 basis set was selected capping all the atomic centers. Stationary 
points were characterized by calculating the Hessian matrix analytically at this level of 
theory. The electronic charge distribution was also analyzed with the Quantum Theory of 
Atoms in Molecules (QTAIM)41 performed with the AIMPAC program suite42 at the 
refined electron density computed at the B3LYP/6-311++G(d,p)39,40 level of theory. 
2.2.8.2. Molecular Dynamics simulations  
The initial geometries of A-FMT (CCDC number: 215086) and IBU (CCDC number: 
1041370) were constructed from the experimental crystal structure. These geometries were 
transferred to AmberTools1743 for the GAFF force field parameters44 assignment and the 
RESP partial charges assigned to reproduce the electrostatic potential determined at the 
HF/6-31G(d) level of theory using Gaussian 09.38 MD simulations of the amorphous FMT-
IBU model system was carried out with a fixed number of 125 molecules of each drug, 
randomly placed in a cubic box subject to the conventional periodic boundary conditions. 
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First of all, the model system was energy minimized until the RMSD of the gradient 
components was less than 0.1 kcal mol-1Å-1. Then, constant volume and temperature (NVT) 
molecular dynamics, starting from a temperature of 50 K and targeting 400 K were 
performed; the quenched system was annealed at 400 K during 5 ns. After that, the system 
was cooled to a final temperature of 298 K at a cooling rate of 0.017 K ps-1. This quench-
and-cooling process was repeated five times starting from the geometrical coordinates 
generated in the previous cycle. Finally, constant pressure and temperature (NPT) 
production stage at 298 K was followed for 600 ns and coordinates were written every 5 ps. 
MD were performed by the GPU implementation of the pmemd program45,46,47 included in 
the AMBER16 suite of programs.48 The Particle Mesh Ewald method49 was employed with 
a direct non-bonded cutoff of 8 Å. A timestep of 1 fs was used in all MD stages. Bonds 
involving hydrogen atoms were constrained with the SHAKE algorithm.50 The temperature 
was controlled with the stochastic Langevin thermostat,51 using a collision frequency of 5 
ps−1. Pressure was controlled with the Berendsen barostat,52 targeting a pressure of 1 bar 
and using a relaxation time of 2 ps. Data for calculation of the RDF of the structure of the 
amorphous state was collected for the last 50 ns of production and averaged to obtain the 
final results. To estimate the Tg a glass was generated by fast cooling the molten system 
from 380 K to 150 K at a cooling rate of 0.03 K ps−1 starting from the last coordinates of 
the model system obtained at the production stage. 
3. RESULTS AND DISCUSSION 
3.1. SOLID STATE CHARACTERIZATION 
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The milling process has demonstrated to be a powerful technique for transforming a 
crystalline drug into its amorphous counterparts;53 thus, it was used to convert the A-FMT 
and IBU binary system in CAM ones. According to the literature, the CAMs at 1:1 molar 
ratio are generally more stable than those in non-equimolar ratios,35,54,55,56,57,58 probably due 
to the formation of dimers. Therefore, in this work the study of the 1:1 FMT-IBU was 
emphasized. However, the 3:7 and 7:3 FMT-IBU phases were also prepared and their 
physicochemical properties were compared with the corresponding ones to the 1:1 FMT-
IBU. The powder X-ray patterns of the 3:7, 1:1 and 7:3 FMT-IBU at different milling times 
are shown in Figure 2. The characteristic halo of amorphous solids is observed in 1:1 and 
7:3 FMT-IBU after 180 minutes of the cryo-milling process. However, diffraction peaks 
derived from A-FMT and IBU in 3:7 FMT-IBU were still present, so this system was 
discarded for further studies.  
The milling process, in the same conditions used for the binary systems (180 minutes and 
30 Hz), was also applied separately to A-FMT and IBU drugs. The XRPD patterns show 
broader diffractions with lower intensity compared with the non-milled ones. Moreover, a 
slightly shifted in the 2θ values of the milled drugs is observed due to the mechanical 
treatment (see Figure 3).  
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Figure 2: Powder X-ray patterns of the FMT-IBU binary systems at different milling times. 
A) 7:3 FMT-IBU, B) 1:1 FMT-IBU and C) 3:7 FMT-IBU. The diffractograms of FMT-IBU 
physical mixtures correspond to 0 minutes. 
 
Figure 3: Powder X-ray patterns of milled (up) and non-milled (down). A) A-FMT and B) 
IBU. 
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 As it is well known, amorphous solids must show not only the absence of diffraction 
peaks, but also the thermal signals inherent to these non-crystalline phases (i.e. Tg). Figure 
4 displays IBU and A-FMT DSC curves as well as the obtained ones for 1:1 and 7:3 FMT-
IBU binary systems. IBU exhibits a sharp melting endotherm at 74.4 ºC, while for A-FMT 
this event is observed at 165.86 ºC (Figure 4A). The DSC thermal curves of 1:1 and 7:3 
FMT-IBU (Figures 4B and 4C, respectively) evidence a different thermal behavior in 
comparison to the pure APIs. Tgs at 45.46 ºC and 37.65 ºC were determined for 1:1 and 7:3 
FMT-IBU, respectively, whereas this event occurs at -49 ºC in IBU and 76 ºC in FMT. 
Moreover, these CAMs show an exothermic event at ~ 85 ºC corresponding to the 
crystallization, followed by an endothermic process assigned to the melting of the now 
crystalline mixtures and almost immediate decomposition (Figure S2). This last event was 
the only one visualized by hot-stage microphotographs in both samples (Figures 4D and 
4E). The occurrence of a single Tg, different enough from those of the isolated APIs, and 
the absence of diffraction peaks, confirm the formation of a homogeneous amorphous solid 
in both cases, where one component is dissolved in the other.59 van Droogue et al.60 
suggest that the Tg value of a non interacting multicomponent system lies in the range 
between the Tgs of the isolated components, as it is observed for FMT-IBU CAMs.    
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Figure 4: DSC curves of A) IBU (black) and A-FMT (red), B) 1:1 FMT-IBU and C) 7:3 
FMT-IBU. Hot-stage microphotographs of D) 1:1 FMT-IBU and E) 7:3 FMT-IBU. (Tg: 
glass transition temperature; Tc: recrystallization temperature; Tm: melting temperature).  
Beyond the previous considerations, it must be taken into account that the comparison of 
the Tg values experimental vs. those by the Gordon-Taylor equation (Equation 1) is also a 
powerful tool to determine the presence of intermolecular interactions in the CAM 
phases.54 In this sense, similar values indicate that there are not intermolecular interactions 
in the CAM systems while different values suggest that the system components are 
intimately interacting. An experimental Tg value smaller than the calculated one can imply 
two possibilities: i: the intermolecular interactions are weaker compared to the pure 
amorphous components61,62 and ii: an increase in the APIs free volume due to grinding 
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process.63 On the other hand, new and stronger intermolecular interactions in the CAMs 
than in the amorphous isolated components are present when the experimental Tg value is 
higher than the calculated one by the equation Gordon-Taylor equation.64    
Table 1 shows the experimental and calculated Tg values corresponding to 1:1 and 7:3 
FMT-IBU CAMs compared with those finding for pure amorphous FMT and IBU. Both 
FMT-IBU CAMs exhibit a positive deviation of the experimental Tg value with respect to 
the calculated ones according to the Gordon-Taylor equation. This fact evidences that FMT 
and IBU are intimately linked through intermolecular interactions; moreover, due to the 
greater deviation of the Tg value in 1:1 FMT-IBU, it is reasonable to assume that the 
strongest interactions are found in this system. 
Table 1: Experimental and calculated Tg values for the amorphous isolated APIs, 1:1 and 
7:3 FMT-IBU CAMs.  
Sample Experimental Tg (ºC) Calculated Tg (ºC) 
FMT 76  - 
IBU -49 - 
1:1 FMT-IBU 45.46 10.9 
7:3 FMT-IBU 37.65  36.33 
It is convenient to remind that the glassy phase is unstable owing to its high energy and 
therefore, can recrystallize to an unwanted crystalline form. The evaluation of the physical 
stability of amorphous phases is performed by the storage of the samples in real time under 
different conditions of temperature and humidity during several periods.65 In this work, the 
stability of the CAM was checked by XRPD and the obtained patterns are shown in Figure 
5. The 7:3 FMT-IBU  
characteristic diffraction peaks belonging to crystalline A-FMT appear for all storage 
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temperatures, mainly in the assay at 40 °C (Figure 5A). On the other hand, in the 1:1 
binary system no typical signals of crystalline drugs were observed (Figure 5B). This high 
physical stability and its higher Tg value, compared to the 7:3 FMT-IBU, denote stronger 
FMT-IBU interactions.  
 
Figure 5: XRPD patterns after 60 days at different storage temperatures. A) 7:3 FMT-IBU 
at a: 4 ºC, b: 25 ºC and c: 40 ºC (The XRPD diagram corresponding to A-FMT is shown in 
Figure 5Ad); B) 1:1 FMT-IBU at a: 4 ºC, b: 25 ºC and c: 40 ºC.  
For the amorphous state, the Tg-50 rule establishes that glass phases are physically stable 
when samples are stored at 50 °C below their corresponding Tg.66 However, 1:1 FMT-IBU 
is stable to the three tested temperatures, none of them 50 ºC lower than its Tg value. 
Therefore, this system is an exception of the Tg-50 rule as it was found for other CAMs 
previously reported.53 This fact suggests that there are different factors that affect the 
stability of amorphous phases like intermolecular interactions. 
Taking into account that the intermolecular interactions are the main stabilizing factor in 
CAMs,35 FTIR analysis was carried out to determine them. Figure 6 shows the FTIR 
spectra of both pure A-FMT and IBU in comparison with the corresponding to the 1:1 
FMT-IBU, while the selected vibrational modes are listed in Table S1. Due to the FTIR 
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spectra complexity, the analysis is focused in those functional groups which could 
potentially participate in intermolecular interactions.  
 
Figure 6: FTIR spectrum of IBU (red), A-FMT (black) and 1:1 FMT-IBU CAM (blue). 
IBU shows the vibrational modes of the carboxylic group at 3343 and 1719 cm-1 which are 
assigned to ν(O1-H) and ν(C1=O2), respectively. On the other hand, two centered sharp 
bands at 3452 and 3411 cm-1 corresponding to ν(N(1 or 2)-H)gua moiety are visualized in the 
A-FMT spectrum, while the bands at 1648 and 1608 cm-1 are consistent with ν(C(1)=N(3))gua 
and δ(N(1 or 2)-H)gua, respectively. Moreover, the vibrational modes of the sulfoxide group 
are observed at 1294 and 1147 cm-1 derived from to νas(S1=O(1 and 2)) y νsym(S1=O(1 and 2)), 
respectively.  
The FTIR spectrum of 1:1 FMT-IBU shows broader bands in comparison with pure drugs; 
this fact strongly suggests modifications in the chemical environment after amorphization 
process.67 Moreover, several shifts in the frequency values are observed in this sample 
regarding to the isolated APIs. In this sense, the ν(C1=O2) of IBU is shifted to a lower 
wavenumber (~ 20 cm-1), while the ν(O1-H) could not be assigned due to the overlapping 
2000 1800 1600 1400 1200 1000
1145
1293
1626
1699
1147
1294
16081648
 
 
Wavenumbers (cm-1)
1719
 
4000 3500 3000 2500
 
 
Wavenumbers (cm-1)
3405
3459
3411
3452
 
3343
A B
T
%
Page 19 of 40
ACS Paragon Plus Environment
The Journal of Physical Chemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
19 
 
with FMT bands. No bands corresponding to the -COO- group were observed indicating 
that no proton transfer between FMT and IBU occurs.  
The vibrational modes of the guanidine moiety in the CAM 1:1 FMT-IBU strongly 
evidence the presence of intermolecular interactions when compared with those observed 
in A-FMT. The ν(N(1 or 2)-H)gua shifts from 3452 – 3411 to 3459 - 3405 cm-1, while the 
bands at 1648 and 1608 cm-1 assigned to ν(C1=N3)gua and δ(N(1 or 2)-H)gua, respectively, 
appear as a unique band at 1626 cm-1 derived from the overlapping of both previous 
mentioned modes. The displacement to a lower frequency of the ν(C1=N3)gua in 1:1 FMT-
IBU CAMs indicates the weakening of this bond. The appearance to a higher frequency of 
the δ(N(1 or 2)-H)gua represents a spectroscopic evidence of H-bond intermolecular 
interactions of greater strength with respect to A-FMT. In fact, the heterosynthon N-H···O 
is energetically more favored than the N-H···N one that is present in A-FMT.33,68 The 
modes corresponding to νas(S1=O(1 and 2)) and νsym(S1=O(1 and 2)) do not show significant 
displacements in comparison with the API thus, any asseveration about new intermolecular 
interactions involving the sulfoxide group would be inconclusive. 
The vibrational behavior of 1:1 FMT-IBU CAMs supports the interaction between FMT 
and IBU through the guanidine and carboxylic moieties, respectively, with possible 
formation of the heterosynthon displayed in Figure 1B. Then, the spectroscopic analysis is 
consistent with the positive deviation of the experimental Tg vs. the calculated (see Table 
1) evidencing intermolecular interactions with such strength that allow us to justify the 
high stability of the present CAMs.  
 
3.2. DFT calculations and Molecular dynamics (MD) simulations 
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3.2.1. Geometric optimization 
In spite of the amorphous systems are characterized by the absence of long-range order, 
they have varying degrees of short-range order by H-bond interactions forming dimers or 
trimers. These arrangements improve physical stability and pharmacokinetic properties 
such as solubility and intrinsic dissolution rate of APIs in co-amorphous phases.10 Taking 
into account the experimental data discussed in this paper, the high physical stability of 1:1 
FMT-IBU can be attributed to intermolecular interactions through heterosynthon formation 
as shown in Figure 1B. In order to analyze the intermolecular interactions demonstrated by 
FTIR spectroscopy between FMT and IBU, ab initio calculations followed by QTAIM 
analysis were performed.  
Crystallographic studies performed by Overgaard, J. et al.33 and Shanklan, N. et al.34 on 
FMT and IBU, respectively, were used to geometrical optimizations. Close agreement were 
found in distances and bond angles when comparing crystallographic vs. DFT results 
(Table S2).  However, expected differences were observed in dihedral angles probably due 
to the low energy involved in the torsional changes after crystallographic packing relax (i.e. 
simple bonds rotations).69 The optimized structures were employed to built the heterodimer 
FMT-IBU.  
Figure 7 presents both conformers (A and B) designed to perform DFT calculation. The 
interaction between the guanidine group of FMT and the carboxilic group belonging to 
IBU, evidenced by FTIR spectroscopy, is present in the conformers. IBU shows a different 
spacial arrangement in the conformer A respect to the B one, about the dihedral angle O2-
C1-C2-C4 whose rotation probably takes place during the milling process.69 The geometrical 
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optimization reveals the conformer A as the minimun energy structure, thus such conformer 
was selected to perform QTAIM analysis.  
 
 
Figure 7: FMT-IBU conformers designed to quantum mechanical optimization. (The 
proposed intermolecular interaction is shown in the orange plane). 
3.2.2. Topological analysis of the electron density 
QTAIM allows the detailed analysis of the electron density distribution calculated by the 
quantum mechanical wavefunction or the quantum mechanical models refined from X-ray 
diffraction data. The Koch and Popelier electronic criteria70  used in this paper were the 
charge density (ρ) and the Laplacian of the charge density (∇2ρ). Molecular graph of 
conformer A is shown in Figure 8 and the bond critical points (BCPs) properties are listed 
in Table 2.  
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Figure 8: Molecular graph of A conformer showing the BCP (green points) and bond paths (purple line). 
Table 2: Geometrical and topological parameters of intermolecular H-bonds found in the A 
conformer.  
D-H···A D-H
a [Å] D···A [Å] H···A [Å] D-H···A[°] Ρ ∇2ρ 
O1(IBU)-H···N3(FMT) 1.015 2.722 1.712 172.24 0.052648 0.097065 
N1(FMT)-H···O2(IBU) 1.023 2.875 1.853 175.33 0.031306 0.107041 
D: donor; A: acceptor 
ρ: charge density: ∇2ρ: Laplacian of the charge density 
Regarding to the Koch and Popelier criteria, BCPs and bond paths between FMT and IBU,  
involving the guanidine and carboxylic groups, respectively, were found (Figure 8, bold 
arrows). The strength and nature of these intermolecular interactions must be evaluated by 
analyzing the topological parameters in the BCPs. According to these authors, the 
numerical analysis of ρ and ∇2ρ in a BCP denotes the strength of interaction, the 
corresponding values being between 0.002 – 0.034 u.a. and 0.024 – 0.139 u.a., respectively. 
The ρ values listed in Table 2 for the proposed conformer are found upper limit in O1(IBU)-
H···N3(FMT) whereas the N1(FMT)-H···O2(IBU) interaction takes a high value. This fact 
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expresses the elevated strength of both intermolecular interactions, O1(IBU)-H···N3(FMT) 
being the stronger one. Moreover, the calculated geometrical parameters are in agreement 
with this ρ value since the D···A and H···A distances are shorter in such interaction.  
This analysis also supports the presence of strong intermolecular interactions involving the 
guanidine group of FMT and the carboxylic one from IBU as responsable of the high 
physical stability of 1:1 FMT-IBU and the positive deviation between experimental and  
calculated Tg values (Table 1).   
3.2.3. Molecular Dynamic Simulations 
MD simulations have been used in amorphous systems to study their dynamic parameters, 
structural properties71 as well as to predict Tg.72 In this sense, MD simulations were carried 
out to evaluate the FMT-IBU heterodimer formation through the intermolecular 
interactions proposed in Figure 1B.  
With the purpose to determine the analogy between the proposed CAM assembly and the 
system prepared by co-milling, the Tg for the first system was obtained and further 
compared with the experimental one. For the co-amorphous assemble, the Tg is obtained by 
MD simulations graphing the change of density as a function of temperature;71 the 
simulated value of the Tg is taken as the intersection point between the straights fitting up 
and below the transition. Linear sections of the corresponding density vs. temperature 
curve were identified by means of the lack-of-fit analysis employing the F-test with a p < 
0.05 for the fits of linear data and starting at 150 or 380 K (Figure 9). 
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Figure 9: Density - temperature phase diagram of the simulated amorphous assembly. The 
system was cooled from 380 to 150 K at a 0.03 K ps-1 rate. The inset shows the DSC curve 
indicating the experimental Tg for the system obtained by co-milling. 
  
The Tg value for a given system varies depending on the method by such amorphous 
material was prepared.72 Even though, the 1:1 FMT-IBU was prepared by co-milling 
whereas quench-cooling (simulated annealing procedure) was employed to simulate the 
corresponding amorphous assembly, both Tg values (experimental and simulated), are in 
good agreement. From these results, it can be assumed that the proposed assembly for 
FMT-IBU closely reproduces the vitreous phase experimentally prepared. 
In order to identify the probability of finding the proposed heterodimer in the simulated 
amorphous assembly the Radial Distribution Function (RDF) was analyzed. 
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Figure 10: RDF curve between the O2 (IBU) and the -N1H (FMT) (blue) and the N3 (FMT) 
and -O1H (IBU) (red). The corresponding profiles derivatives are shown in dash lines. 
The RDF profile at 298 K for the amorphous assembly is shown in Figure 10 where only 
the atoms involved in those interactions proposed in Figure 1B, are displayed. Two sharp 
peaks can be observed for O2(IBU)···H(FMT) and N3(FMT)···H(IBU) pairs at 1.75 and 1.88 Å, 
respectively; these results are clearly consistent with the presence of such proposed FMT 
and IBU intermolecular interactions. The values obtained by RDF for the corresponding 
interatomic distances fit well with those calculated by DFT geometrical optimization 
(Table 2), indicating that the geometry and strength of the interactions analyzed by 
QTAIM are maintained in the proposed thermodynamic amorphous assembly. 
RDF analysis confirms the intermolecular interactions N3-H···O1 and O2-H···N1, however, 
the presence of the heterodimers formed via these interactions, that give rise to eight-
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members rings (R2
2
8	), could not be demonstrated. Therefore, a manual searching inside the 
proposed amorphous phase was performed with the aim to identify such species. Figure 11 
(A-D) displays the obtained results where such H-bonding motifs are present. In addition to 
these interactions, FMT and IBU are also forming heterodimers R 2
2
8 based in a N-H···O 
heterosynthon involving the amino groups of the guanidine moiety (FMT) as H-donors and 
the IBU carboxylic one (Figure S3 A-B). Moreover, interactions between the amino group 
belonging to the sulfamoyl moiety (FMT) and the IBU carboxylic one were also found 
(Figure S3 C). Chain-type interactions determining trimers and H-bonds between the 
guanidine moiety and the IBU hydroxyl group (N3(FMT)···H-O1(IBU)) could be observed too 
(Figure S3 D and E, respectively). No evidences of intermolecular interactions involving 
the O atoms of the sulfamoyl group as H-bond acceptors were found, consistent with the 
FTIR experimental data. It is worth mentioning that the variety of H-bonds found in the 
simulated amorphous assembly, allows us to justify the broadening of the bands in the 
FTIR spectrum of 1:1 FMT-IBU since a same functional group is present in different 
chemical environments. 
 
Figure 11: Significant H-bond interactions found in the simulated amorphous assembly. 
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4. CONCLUSIONS  
Famotidine and ibuprofen were selected as models drugs to obtain a co-amorphous system 
through the co-milling technique, rationally designed for stabilizing by formation of 
heterodimers between both drugs. Three binary systems in 3:7, 1:1 and 7:3 molar ratios of 
A-FMT and IBU, respectively, were prepared; the latter ones were completely converted 
into the amorphous state after 180 minutes of co-milling. Contrarily, no amorphous solids 
were obtained when the same mechanical process was applied separately to A-FMT and 
IBU. This fact confirms that the crystalline order of each drug is easier to disorganize when 
both drugs are milled together, associated to the formation of more stable intermolecular 
interactions. The stability assays evidenced the poor physical stability of the 7:3 FMT-IBU 
whereas the corresponding 1:1 system retains its amorphous nature under the tested 
conditions, suggesting the presence of strong intermolecular interactions that prevent re-
crystallization of the isolated drugs. In this sense, N3(FMT)···H-O1(IBU) and N1-
H(FMT)···O2(IBU) H-bonds were particularly assessed as those able to form a R
2
2
8 structural 
motif. The formation of the expected intermolecular interactions was supported by 
modifications of the 1:1 FMT-IBU FTIR spectrum in comparison with those of the pure 
APIs. DFT calculations allowed us to select the minimum energy heterodimer; further 
QTAIM analysis suggests a high strength of the proposed interactions. MD simulations 
along with a simulated annealing procedure were employed to construct a thermodynamic 
amorphous assembly that resulted in an adequate and realistic representation of the 
experimentally obtained vitreous phase, according to the close Tgs values (simulated and 
experimental). RDF curves account for the expected intermolecular interactions but not the 
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formation of the R2
2
8 motif, which could be detected performing a manual searching into 
the simulated amorphous assemble. In summary, this work proposes that a co-amorphous 
binary system, physically stable, could be rationally designed by selecting components 
without other competitive interactions, able to prevent the desired structural motif. 
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